Citations

Showing 10 of 108119 citations.

The Sicker Are Sicker: A Tale of Late Outcome After Sepsis*
Bauer, Philippe R.

Mayo Clinic

Critical Care Medicine | March 17, 2019 | Volume: 47 | Issue: 4 | Pages: 610-611

10.1097/ccm.0000000000003676 | PMID 30882433 Get It

Critical Care Ultrasound Should Be a Priority First-Line Assessment Tool in Neurocritical Care
Díaz‐Gómez, José L. , Díaz-Gómez, José L , Rajajee, Venkatakrishna

Mayo Clinic

Critical Care Medicine | March 17, 2019 | Volume: 47 | Issue: 6 | Pages: 833-836

10.1097/ccm.0000000000003712 | PMID 30870190 Get It

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis
Minamisawa, Masatoshi, Claggett, Brian , Adams, David , Kristen, Arnt V. , Merlini, Giampaolo , Slama, Michel , Shah, Amil M. , Falk, Rodney H. , Karsten, Verena, Sweetser, Marianne T., Riese, Richard J. , Vest, John, Solomon, Scott D. , Merlini, Giampaolo , Adams, David , Shah, Amil , Dispenzieri, Angela , Falk, Rodney H , Chen, Jihong , Vest, John, Solomon, Scott David

Mayo Clinic

JAMA Cardiology | March 16, 2019 | Volume: 4 | Issue: 5 | Pages: 466

10.1001/jamacardio.2019.0849 | PMID 30878017 Get It

Infectious encephalitis: mimics and chameleons
Toledano, Michel , Davies, Nicholas

Mayo Clinic

Practical Neurology | March 16, 2019 | Volume: 19 | Issue: 3 | Pages: 225-237

10.1136/practneurol-2018-002114 | PMID 30878971 Get It

‘Query encephalitis’ is a common neurological consultation in hospitalised patients. Identifying the syndrome is only part of the puzzle. Although historically encephalitis has been almost synonymous with infection, we increasingly recognise parainfectious or postinfectious as well as other immune-mediated causes. We must also distinguish encephalitis from other causes of encephalopathy, including systemic infection, metabolic derangements, toxins, inherited metabolic disorders, hypoxia, trauma and vasculopathies. Here, we review the most important differential diagnoses (mimics) of patients presenting with an encephalitic syndrome and highlight some unusual presentations (chameleons) of infectious encephalitis.
Conversation: Beyond black boxes: tackling artificial intelligence as a design material
Berzowska, Joanna, O'Murchu, Nora, Kelliher, Aisling , Barry, Barbara , Smeaton, Alan F.

Mayo Clinic

Proceedings of DRS | March 16, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21606/drs.2018.784 Get It

Epidemiology of Shock in Contemporary Cardiac Intensive Care Units
Berg, David D. , Bohula, Erin A. , Katz, Jason N. , Alviar, Carlos L. , Baird-Zars, Vivian M., Barsness, Gregory W. , Burke, James A. , Cremer, Paul , Cruz, Jennifer , Daniels, Lori B. , DeFilippis, Andrew P. , Haleem, Affan , Hollenberg, Steven M. , Horowitz, James M. , Keller, Norma, Kontos, Michael C. , Lawler, Patrick R. , Menon, Venu , Metkus, Thomas S. , Ng, Jason, Orgel, Ryan, Overgaard, Christopher B., Park, Jeong-Gun, Phreaner, Nicholas , Roswell, Robert O. , Schulman, Steven P. , Snell, R. Jeffrey, Solomon, Michael A. , Ternus, Bradley , Tymchak, Wayne , Vikram, Fnu, Morrow, David A. , Lawler, Patrick , Solomon, Michael A , Morrow, David A , Roswell, Robert O , Daniels, Lori B , Bohula, Erin A , Cremer, Paul C , Berg, David , Diepen, Sean van , Barnett, Christopher F. , Burke, James A., Park, Jeong‐Gun

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 16, 2019 | Volume: 12 | Issue: 3 | Pages: No page available

10.1161/circoutcomes.119.005618 | PMID 30879324 Get It

Background Clinical investigations of shock in cardiac intensive care units (CICUs) have primarily focused on acute myocardial infarction (AMI) complicated by cardiogenic shock (AMICS). Few studies have evaluated the full spectrum of shock in contemporary CICUs. Methods and Results The Critical Care Cardiology Trials Network is a multicenter network of advanced CICUs in North America. Anytime between September 2017 and September 2018, each center (n=16) contributed a 2-month snap-shot of all consecutive medical admissions to the CICU. Data were submitted to the central coordinating center (TIMI Study Group, Boston, MA). Shock was defined as sustained systolic blood pressure <90 mm Hg with end-organ dysfunction ascribed to the hypotension. Shock type was classified by site investigators as cardiogenic, distributive, hypovolemic, or mixed. Among 3049 CICU admissions, 677 (22%) met clinical criteria for shock. Shock type was varied, with 66% assessed as cardiogenic shock (CS), 7% as distributive, 3% as hypovolemic, 20% as mixed, and 4% as unknown. Among patients with CS (n=450), 30% had AMICS, 18% had ischemic cardiomyopathy without AMI, 28% had nonischemic cardiomyopathy, and 17% had a cardiac cause other than primary myocardial dysfunction. Patients with mixed shock had cardiovascular comorbidities similar to patients with CS. The median CICU stay was 4.0 days (interquartile range [IQR], 2.5–8.1 days) for AMICS, 4.3 days (IQR, 2.1–8.5 days) for CS not related to AMI, and 5.8 days (IQR, 2.9–10.0 days) for mixed shock versus 1.9 days (IQR, 1.0–3.6) for patients without shock ( P <0.01 for each). Median Sequential Organ Failure Assessment scores were higher in patients with mixed shock (10; IQR, 6–13) versus AMICS (8; IQR, 5–11) or CS without AMI (7; IQR, 5–11; each P <0.01). In-hospital mortality rates were 36% (95% CI, 28%–45%), 31% (95% CI, 26%–36%), and 39% (95% CI, 31%–48%) in AMICS, CS without AMI, and mixed shock, respectively. Conclusions The epidemiology of shock in contemporary advanced CICUs is varied, and AMICS now represents less than one-third of all CS. Despite advanced therapies, mortality in CS and mixed shock remains high. Investigation of management strategies and new therapies to treat shock in the CICU should take this epidemiology into account.
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists
Brusca, Samuel B. , Barnett, Christopher F. , Barnhart, Brendan J. , Weng, Weifeng , Soble, Jeffrey S., Katz, Jason N. , Wiley, Brandon M. , Gomez, A.D., Solomon, Michael A. , Solomon, Michael A , Morrow, David A. , Diepen, Sean van

Mayo Clinic

Journal of the American Heart Association | March 16, 2019 | Volume: 8 | Issue: 6 | Pages: No page available

10.1161/jaha.118.011721 | PMID 30879373 Get It

Background Cardiovascular intensive care units ( CICUs ) have evolved from coronary care wards into distinct units for critically ill patients with primary cardiac diseases, often suffering from illnesses that cross multiple disciplines. Mounting evidence has demonstrated improved survival with the incorporation of dedicated CICU providers with expertise in critical care medicine ( CCM ). This is the first study to systematically survey dual certified physicians in order to assess the relevance of CCM training to contemporary CICU care. Methods and Results Utilizing American Board of Internal Medicine data through 2014, 397 eligible physicians had obtained initial certification in both cardiovascular disease and CCM . A survey to delineate the role of critical care training in the CICU was provided to these physicians. Among those surveyed, 120 physicians (30%) responded. Dual certified physicians reported frequent use of their CCM skills in the CICU , highlighting ventilator management, multiorgan dysfunction management, end‐of‐life care, and airway management. The majority (85%) cited these skills as the reason CCM training should be prioritized by future CICU providers. Few (17%) agreed that general cardiology fellowship alone is currently sufficient to care for patients in the modern CICU . Furthermore, there was a consensus that there is an unmet need for cardiologists trained in CCM (70%) and that CICU s should adopt a level system similar to trauma centers (61%). Conclusions Citing specific skills acquired during CCM training, dual certified critical care cardiologists reported that their additional critical care experience was necessary in their practice to effectively deliver care in the modern CICU .
Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis
Singh, Siddharth , Singh, Abha G., Dulai, Parambir S. , Sandborn, William J. , Curtis, Jeffrey R. , Singh, Namrata , Curtis, Jeffrey R , Fumery, Mathurin , Prokop, Larry J.

Mayo Clinic

Arthritis Care & Research | March 16, 2019 | Volume: 72 | Issue: 4 | Pages: 561-576

10.1002/acr.23875 | PMID 30875456 Get It

ObjectiveWe performed a systematic review and meta‐analysis to evaluate the comparative effects of tumor necrosis factor inhibitors (TNFi), non‐TNFi biologics, and conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) on cardiovascular risk in rheumatoid arthritis (RA).MethodsUsing a systematic search through May 8, 2018, we included 14 observational studies in adults with RA treated with TNFi, non‐TNFi biologics, tofacitinib, or csDMARDs, reporting the risk of major adverse cardiovascular events (MACE) or stroke. Only studies reporting active comparators were included. We performed random effects meta‐analysis and estimated odds ratios (ORs) and 95% confidence intervals (95% CIs).ResultsAs compared to TNFi, tocilizumab was associated with a decreased risk of MACE (OR 0.59 [95% CI 0.34–1.00]), whereas csDMARDs were associated with an increased risk of MACE (csDMARDs including methotrexate OR 1.45 [95% CI 1.09–1.93]; without methotrexate OR 2.57 [95% CI 1.32–5.00]), without heterogeneity (I2 = 0%); there was no difference in risk of MACE between abatacept and TNFi (OR 0.89 [95% CI 0.71–1.11]), or between tocilizumab and abatacept (OR 0.81 [0.57–1.16]). Based on 11 cohorts (n = 135,053 patients), as compared to TNFi, csDMARDs were associated with an increased risk of stroke (OR 1.17 [95% CI 1.01–1.36]); there was no difference in risk of stroke between different biologics (tocilizumab versus TNFi OR 0.98 [95% CI 0.59–1.61]; abatacept versus TNFi OR 1.08 [0.86–1.34]; tocilizumab versus abatacept OR 0.73 [95% CI 0.39–1.38]), without heterogeneity (I2 = 0%). No comparative studies on cardiovascular risk with tofacitinib were identified.ConclusionBased on meta‐analysis, as compared to TNFi, tocilizumab may be associated with a reduced risk of MACE, whereas csDMARDs may be associated with an increased risk of MACE and stroke.
Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria
Kim, Hyun Ah , Bisdorff, Alexandre , Bronstein, Adolfo M. , Lempert, Thomas , Rossi-Izquierdo, Marcos , Kim, Ji‐Soo , Staab, Jeffrey P. , Strupp, Michael Leo

Mayo Clinic

Journal of Vestibular Research | March 15, 2019 | Volume: 29 | Issue: 2-3 | Pages: 45-56

10.3233/ves-190655 | PMID 30883381 Get It

This paper presents the diagnostic criteria for hemodynamic orthostatic dizziness/vertigo to be included in the International Classification of Vestibular Disorders (ICVD). The aim of defining diagnostic criteria of hemodynamic orthostatic dizziness/vertigo is to help clinicians to understand the terminology related to orthostatic dizziness/vertigo and to distinguish orthostatic dizziness/vertigo due to global brain hypoperfusion from that caused by other etiologies. Diagnosis of hemodynamic orthostatic dizziness/vertigo requires: A) five or more episodes of dizziness, unsteadiness or vertigo triggered by arising or present during upright position, which subsides by sitting or lying down; B) orthostatic hypotension, postural tachycardia syndrome or syncope documented on standing or during head-up tilt test; and C) not better accounted for by another disease or disorder. Probable hemodynamic orthostatic dizziness/vertigo is defined as follows: A) five or more episodes of dizziness, unsteadiness or vertigo triggered by arising or present during upright position, which subsides by sitting or lying down; B) at least one of the following accompanying symptoms: generalized weakness/tiredness, difficulty in thinking/concentrating, blurred vision, and tachycardia/palpitations; and C) not better accounted for by another disease or disorder. These diagnostic criteria have been derived by expert consensus from an extensive review of 90 years of research on hemodynamic orthostatic dizziness/vertigo, postural hypotension or tachycardia, and autonomic dizziness. Measurements of orthostatic blood pressure and heart rate are important for the screening and documentation of orthostatic hypotension or postural tachycardia syndrome to establish the diagnosis of hemodynamic orthostatic dizziness/vertigo.
In Silico Performance of a Recellularized Tissue-Engineered Transcatheter Aortic Valve
Noble, Christopher , Choe, Joshua A. , Uthamaraj, Susheil , DeHerrera, Milton, Young, Melissa , Choe, Joshua, Lerman, Amir

Mayo Clinic

Journal of Biomechanical Engineering | March 15, 2019 | Volume: 141 | Issue: 6 | Pages: 061004-061004-12

10.1115/1.4043209 | PMID 30874717 Get It

Commercially available heart valves have many limitations, such as a lack of remodeling, risk of calcification, and thromboembolic problems. Many state-of-the-art tissue-engineered heart valves (TEHV) rely on recellularization to allow remodeling and transition to mechanical behavior of native tissues. Current in vitro testing is insufficient in characterizing a soon-to-be living valve due to this change in mechanical response; thus, it is imperative to understand the performance of an in situ valve. However, due to the complex in vivo environment, this is difficult to accomplish. Finite element (FE) analysis has become a standard tool for modeling mechanical behavior of heart valves; yet, research to date has mostly focused on commercial valves. The purpose of this study has been to evaluate the mechanical behavior of a TEHV material before and after 6 months of implantation in a rat subdermis model. This model allows the recellularization and remodeling potential of the material to be assessed via a simple and inexpensive means prior to more complex ovine orthotropic studies. Biaxial testing was utilized to evaluate the mechanical properties, and subsequently, constitutive model parameters were fit to the data to allow mechanical performance to be evaluated via FE analysis of a full cardiac cycle. Maximum principal stresses and strains from the leaflets and commissures were then analyzed. The results of this study demonstrate that the explanted tissues had reduced mechanical strength compared to the implants but were similar to the native tissues. For the FE models, this trend was continued with similar mechanical behavior in explant and native tissue groups and less compliant behavior in implant tissues. Histology demonstrated recellularization and remodeling although remodeled collagen had no clear directionality. In conclusion, we observed successful recellularization and remodeling of the tissue giving confidence to our TEHV material; however, the mechanical response indicates the additional remodeling would likely occur in the aortic/pulmonary position.